Bosentan enhances in vitro bortezomib's anti-proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade.

Schäfer, Julia; Weiss, Johanna; Theile, Dirk

Bosentan enhances in vitro bortezomib's anti-proliferative potency against multiple myeloma by mechanisms going beyond endothelin receptor blockade.

Schäfer, Julia; Weiss, Johanna; Theile, Dirk.

Afiliação

Schäfer J; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.
Weiss J; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.
Theile D; Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.

Br J Haematol ; 184(6): 1052-1055, 2019 03.

Article em En | MEDLINE | ID: mdl-29676451

Assuntos

Mieloma Múltiplo; Bortezomib; Bosentana; Endotelina-1; Humanos; Receptor de Endotelina A

Palavras-chave

bortezomib; bosentan; endothelin; multiple myeloma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google